Status:

COMPLETED

50 Human Subject Repeat Insult Patch Test

Lead Sponsor:

CAGE Bio Inc.

Collaborating Sponsors:

AMA Laboratories Inc.

Conditions:

Erythema

Sensitisation

Eligibility:

All Genders

21-67 years

Phase:

NA

Brief Summary

Consumer products or raw materials designed for consistent reapplication to areas of the skin may, under proper conditions, prove to be contact sensitizers or irritants in certain individuals. It is t...

Eligibility Criteria

Inclusion

  • Individuals who are not currently under a doctor's care
  • Individuals free of any dermatological or systemic disorder which would interfere with the results, at the discretion of the Investigator.
  • Individuals free of any acute or chronic disease that might interfere with or increase the risk of study participation.
  • Individuals who will complete a preliminary medical history form mandated by AMA Laboratories, Inc. and are in general good health.
  • Individuals, who will read, understand and sign an informed consent document relating to the specific type of study they are subscribing. Consent forms are kept on file and are available for examination on the premises of AMA Laboratories, Inc. only.
  • Individuals able to cooperate with the Investigator and research staff, willing to have test materials applied according to the protocol, and complete the full course of the study.

Exclusion

  • Individuals under 18 years of age.
  • Individuals who are currently under a doctor's care.
  • Individuals who are currently taking any medication (topical or systemic) that may mask or interfere with the test results.
  • Subjects with a history of any acute or chronic disease that might interfere with or increase the risk associated with study participation.
  • Individuals diagnosed with chronic skin allergies.
  • Female volunteers who indicate that they are pregnant or lactating.

Key Trial Info

Start Date :

January 18 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 2 2017

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT04498676

Start Date

January 18 2017

End Date

March 2 2017

Last Update

August 4 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

AMA Laboratories Inc.

New City, New York, United States, 10956